These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 30665284
21. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study. Micari A, Vadalà G, Castriota F, Liso A, Grattoni C, Russo P, Marchese A, Pantaleo P, Roscitano G, Cesana BM, Cremonesi A. JACC Cardiovasc Interv; 2016 May 09; 9(9):950-6. PubMed ID: 27151609 [Abstract] [Full Text] [Related]
22. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E. J Endovasc Ther; 2014 Jun 09; 21(3):359-68. PubMed ID: 24915582 [Abstract] [Full Text] [Related]
23. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. Sixt S, Carpio Cancino OG, Treszl A, Beschorner U, Macharzina R, Rastan A, Krankenberg H, Neumann FJ, Zeller T. J Vasc Surg; 2013 Sep 09; 58(3):682-6. PubMed ID: 23755977 [Abstract] [Full Text] [Related]
24. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry. Schmidt A, Piorkowski M, Görner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D. JACC Cardiovasc Interv; 2016 Apr 11; 9(7):715-24. PubMed ID: 27056311 [Abstract] [Full Text] [Related]
27. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials. Giacoppo D, Cassese S, Harada Y, Colleran R, Michel J, Fusaro M, Kastrati A, Byrne RA. JACC Cardiovasc Interv; 2016 Aug 22; 9(16):1731-42. PubMed ID: 27539695 [Abstract] [Full Text] [Related]
28. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment. Bausback Y, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D, RANGER SFA Investigators. J Endovasc Ther; 2017 Aug 22; 24(4):459-467. PubMed ID: 28558502 [Abstract] [Full Text] [Related]
29. Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions. Zeller T, Lopez L, Pigott JP. J Endovasc Ther; 2019 Jun 22; 26(3):333-341. PubMed ID: 31106694 [Abstract] [Full Text] [Related]
33. Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions. Yiğit G. Vascular; 2022 Aug 22; 30(4):739-748. PubMed ID: 34180304 [Abstract] [Full Text] [Related]
35. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial. Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H, MDT-2113 SFA Japan Investigators. J Endovasc Ther; 2018 Feb 22; 25(1):109-117. PubMed ID: 29264999 [Abstract] [Full Text] [Related]